Takeda Pharmaceutical Company Limited
Treatment of .alpha.-galactosidase a deficiency

Abstract:

The invention provides methods of treating .alpha.-galactosidase A deficiency. Dosage forms, methods of administration, and methods of analyzing human .alpha.-galactosidase A are also included.